IL1B and breast carcinoma: Moreover, inflammatory cytokines, such as interleukin (IL)-6, induce LCN2 expression depending on activation of the STAT3 signaling pathway, IL-1β and the tumor cell-derived factor IL-10 also promote LCN2 expression in lung [31] and breast cancer [32].